-
-
-
-
-
-
-
Aurinia Pharmaceuticals (AUPH) Shareholder Calls for CEO Peter Greenleaf, Dr. Brinda Balakrishnan, and Dr. Robert Foster to Resign from the Board
-
-
-
-
-
-
-
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value
-
101,922 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

